Target-Based Approach to Inhibitors of Histone Arginine Methyltransferases
Authors:
- Ralf HeinkeRHRalf Heinke
- Ingo BauerIBIngo Bauer
- Patrick TrojerPTPatrick Trojer
- Eric MetzgerEMEric Metzger
- Ronald GustRGRonald Gust
- Roland SchüleRSRoland Schüle
- Gerald BroschGBGerald Brosch
- Wolfgang SipplWolfgang Sippl
- Manfred JungMJManfred Jung
- 14 April 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (10) , 2319-2325
Abstract
Lysine and arginine methyltransferases participate in the post-translational modification of histones and regulate key cellular functions. So far only one arginine methyltransferase inhibitor discovered by random screening was available. We present the first target-based approach to protein arginine methyltransferase (PRMT) inhibitors. Homology models of human and Aspergillus nidulans PRMT1 were generated from available X-ray structures of rat PRMTs. The NCI diversity set was filtered by a target-based virtual screening to identify PRMT inhibitors. Employing a fungal PRMT for screening and a human enzyme for validation, we have identified seven inhibitors of PRMTs in vitro. Hit validation was achieved for two new inhibitors by antibody mediated detection of histone hypomethylation as well as Western blotting in cancer cells. Functional activity was proven by an observed block of estrogen receptor activation. Thus, valuable chemical tools and potential drug candidates could be identified.Keywords
This publication has 17 references indexed in Scilit:
- Chromatin Modifications as Targets for New Anticancer DrugsArchiv der Pharmazie, 2005
- SIRT1 Regulates HIV Transcription via Tat DeacetylationPLOS Biology, 2005
- Investigations on the Effects of Basic Side Chains on the Hormonal Profile of (4R,5S)/(4S,5R)-4,5-Bis(4-hydroxyphenyl)-2-imidazolinesJournal of Medicinal Chemistry, 2004
- Regulation of p53 activity through lysine methylationNature, 2004
- Acetylation inactivates the transcriptional repressor BCL6Nature Genetics, 2002
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Translating the Histone CodeScience, 2001
- Regulation of Transcription by a Protein MethyltransferaseScience, 1999
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- A computational procedure for determining energetically favorable binding sites on biologically important macromoleculesJournal of Medicinal Chemistry, 1985